Inventor · disambiguated record
Patrick M. Lippiello
Also filed as: LIPPIELLO PATRICK M · LIPPIELLO PATRICK MICHAEL
31 granted patents·4 pending applications·1,771 citations·filing 1990–2011
98Inventor score
Files withREYNOLDS TOBACCO CO R11TARGACEPT INC7CALDWELL WILLIAM S1R J REYNOLDS TABACCO COMPANY1TOLER STEVEN M1
Top patents by PatentIndex Score
35 records- 0198US5861423APharmaceutical compositions incorporating aryl substituted olefinic amine compoundsFiled 1997·Granted Jan 19, 1999·119 cites·12 claims
- 0298US5583140APharmaceutical compositions for the treatment of central nervous system disordersFiled 1995·Granted Dec 10, 1996·181 cites·15 claims
- 0395US5604231APharmaceutical compositions for prevention and treatment of ulcerative colitisFiled 1995·Granted Feb 18, 1997·329 cites·21 claims
- 0493US5824692APharmaceutical compositions for prevention and treatment of central nervous system disordersFiled 1995·Granted Oct 20, 1998·67 cites·26 claims
- 0593US5212188AMethod for treatment of neurodegenerative diseasesR J REYNOLDS TABACCO COMPANY·Filed 1992·Granted May 18, 1993·148 cites·18 claims
- 0692US6232316B1Methods for treatment of CNS disordersTARGACEPT INC·Filed 1998·Granted May 15, 2001·48 cites·9 claims
- 0791US6274606B1Methods of treating central nervous system disorders with aryl substituted olefinic amine compoundsTARGACEPT INC·Filed 1998·Granted Aug 14, 2001·46 cites·16 claims
- 0891US5811442APharmaceutical compositions for the treatment of conditions associated with decreased blood flowFiled 1997·Granted Sep 22, 1998·109 cites·46 claims
- 0990US5276043AMethod for treatment of neurodegenerative diseasesREYNOLDS TOBACCO CO R·Filed 1993·Granted Jan 4, 1994·74 cites·14 claims
- 1089US5952339APharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter releaseFiled 1998·Granted Sep 14, 1999·96 cites·34 claims
- 1187US5227391AMethod for treatment of neurodegenerative diseasesREYNOLDS TOBACCO CO R·Filed 1992·Granted Jul 13, 1993·58 cites·11 claims
- 1286US5885998AMethods for prevention and treatment of attention deficit disorderFiled 1998·Granted Mar 23, 1999·28 cites·18 claims
- 1383US6979695B2Compounds capable of activating cholinergic receptorsTARGACEPT INC·Filed 2002·Granted Dec 27, 2005·13 cites·37 claims
- 1483US5031646ACigaretteREYNOLDS TOBACCO CO R·Filed 1990·Granted Jul 16, 1991·100 cites·34 claims
- 1581US5510355ADepolarizing skeletal muscle relaxantsFiled 1994·Granted Apr 23, 1996·51 cites·14 claims
- 1681US5242935AMethod for treatment of neurodegenerative diseasesREYNOLDS TOBACCO CO R·Filed 1992·Granted Sep 7, 1993·39 cites·24 claims
- 1780US6525065B1Pharmaceutical compositions and methods for effecting dopamine releaseTARGACEPT INC·Filed 1997·Granted Feb 25, 2003·24 cites·11 claims
- 1879US7045538B2Compounds capable of activating cholinergic receptorsTARGACEPT INC·Filed 2004·Granted May 16, 2006·8 cites·9 claims
- 1978US5232933AMethod for treatment of neurodegenerative diseasesREYNOLDS TOBACCO CO R·Filed 1992·Granted Aug 3, 1993·35 cites·18 claims
- 2076US5227385AMethod for treatment of neurodegenerative diseasesUNIV WAKE FOREST·Filed 1992·Granted Jul 13, 1993·31 cites·30 claims
- 2175US5242934AMethod for treatment of neurodegenerative diseasesREYNOLDS TOBACCO CO R·Filed 1992·Granted Sep 7, 1993·28 cites·24 claims
- 2273US5731314APharamceutical compositions for prevention and treatment of tourette's syndromeFiled 1995·Granted Mar 24, 1998·29 cites·4 claims
- 2371US5248690AMethod for treatment of neurodegenerative diseasesREYNOLDS TOBACCO CO R·Filed 1992·Granted Sep 28, 1993·33 cites·19 claims
- 2468US5922723APharmaceutical compositions for prevention and treatment of central nervous system disordersFiled 1996·Granted Jul 13, 1999·9 cites·14 claims
- 2568US2010121061A1Compounds capable of activating cholinergic receptorsTARGACEPT INC·Filed 2009·Application pending·0 cites
- 2659US6100269APharmaceutical compositions for prevention and treatment of central nervous system disordersFiled 1999·Granted Aug 8, 2000·5 cites·13 claims
- 2759US2011098312A1Methods for preventing the development of retinopathy by the oral administration of nnr ligandsTARGACEPT INC·Filed 2009·Application pending·0 cites
- 2858US2006293289A1Compounds Capable of Activating Cholinergic ReceptorsCALDWELL WILLIAM S·Filed 2006·Application pending·0 cites
- 2957US5242916AMethod for treatment of neurodegenerative diseasesREYNOLDS TOBACCO CO R·Filed 1992·Granted Sep 7, 1993·11 cites·14 claims
- 3056US6107298AMethods for prevention and treatment of Tourette's syndrome and schizophreniaFiled 1999·Granted Aug 22, 2000·13 cites·4 claims
- 3156US5559124ADepolarizing skeletal muscle relaxantsFiled 1995·Granted Sep 24, 1996·14 cites·8 claims
- 3254US5214060AMethod for treatment of neurodegenerative diseasesREYNOLDS TOBACCO CO R·Filed 1992·Granted May 25, 1993·9 cites·18 claims
- 3350US5187169AMethod for treatment of neurodegenerative diseasesREYNOLDS TOBACCO CO R·Filed 1992·Granted Feb 16, 1993·13 cites·12 claims
- 3435US5232932AMethod for treatment of neurodegenerative diseasesREYNOLDS TOBACCO CO R·Filed 1992·Granted Aug 3, 1993·3 cites·15 claims
- 3525US2013237550A1Arylvinylazacycloalkane compounds for constipationTOLER STEVEN M·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →